What is Cardiomyopathies Matter?
Cardiomyopathies Matter is a multi-stakeholder initiative funded by Bristol Myers Squibb and Philips that aims to raise awareness of cardiomyopathies among policy-makers and to ensure these health conditions are given the policy attention they warrant both at national and EU levels.
A shared space for
stakeholders
Our latest articles
Save the Date: Multistakeholder-event on cardiomyopathies on January 22
Cardiomyopathies Matter Spain will present a report identifying key challenges…
Save the Date: Multistakeholder-event on cardiomyopathies on February 21
Cardiomyopathies, a group of diseases affecting the heart muscle, are…
New publication – Family matters: tackling inherited cardiomyopathies in the next EU policy mandate
In cardiomyopathy care, family matters. A causative genetic variant can…